Information Update - Epilepsy Drug Zarontin: Defective Softgel Capsules May Reduce Drug's Effectiveness

Zarontin Recall Summary Zarontin (ethosuximide) softgel capsules sold in Canada may be defective and not work as intended to treat epilepsy. The defective capsules could reduce the drug's effectiveness. This recall affects Zarontin products distributed across Canada.

Reason

Product safety

Category

consumer product recall

Country

Canada

Agency

HC-PRODUCTS

Recall date

2016-09-22

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-PRODUCTS

Recall details on Nibble Recalls: https://trynibble.app/recalls/38a280d2-a3f8-4c4d-a3a1-aba39082f554